This company seems to have been delisted
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Isoray
ISR
$0.62
Share price
0.00%
Change (1 day)
47.33%
Change (1 year)
Categories
P/S ratio for Isoray (ISR)
P/S ratio on April 21, 2023 (TTM) : 11.9
According to Isoray 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.95. At the end of 2022 the company had a P/S ratio of 3.92.
P/S ratio history for Isoray from 2003 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 3.92 | -23.93% |
| 2021 | 5.15 | 29.87% |
| 2020 | 3.96 | -21.16% |
| 2019 | 5.03 | 65.32% |
| 2018 | 3.04 | -25.26% |
| 2017 | 4.07 | -43.54% |
| 2016 | 7.21 | -30.85% |
| 2015 | 10.4 | -45.49% |
| 2014 | 19.1 | 360.65% |
| 2013 | 4.15 | -28.33% |
| 2012 | 5.79 | 52.89% |
| 2011 | 3.79 | -33.69% |
| 2010 | 5.71 | 48.79% |
| 2009 | 3.84 | 434.62% |
| 2008 | 0.7180 | -89.31% |
| 2007 | 6.71 | -68.58% |
| 2006 | 21.4 | -84.65% |
| 2005 | 139 | |
| 2004 | N/A | |
| 2003 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 0.3654 | -96.94% | 🇺🇸 USA |
 | 1.40 | -88.28% | 🇺🇸 USA |
 | 3.34 | -72.05% | 🇺🇸 USA |
 | 4.32 | -63.84% | 🇺🇸 USA |